Pharmaceuticals company Pfizer, which manufactures the epilepsy medicine phenytoin sodium capsules, has been fined a record £84.2 million by the Competition and Markets Authority (CMA). The company has been found to be breaking competition law by charging what the CMA said were 'excessive and unfair' prices in the UK for the medicine.
Pfizer and Flynn Pharma fined a record £90... - Epilepsy Action
Pfizer and Flynn Pharma fined a record £90 million for ‘excessive and unfair’ price hikes for phenytoin.7 December, 2016
EpilepsyAction1PartnerEpilepsy Action
Written by
EpilepsyAction1
Partner
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
Moderation team
EpilepsyAction-DTModerator
EpilepsyAction1Partner
